​

Funding Round

Venture Round - Medisyn Technologies

Venture Round - Medisyn Technologies

Investment Firm

Overview

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

Announced Date

Feb 17, 2005

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorAndcor Companies
Participant InvestorPortage Capital
Participant InvestorStarTec Investments
Participant InvestorSherpa Partners
Participant InvestorMTI Ventures

Round Details and Background

Medisyn Technologies raised $1500000 on 2005-02-17 in Venture Round

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 17, 2005
Venture Round - Medisyn Technologies
5-1.5M

Recent Activity

There is no recent news or activity for this profile.